Carolinas Wealth Consulting’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4
| Closed | -$687 | – | 1055 |
|
|
2023
Q2 | $687 | Hold |
4
| – | – | ﹤0.01% | 955 |
|
|
2023
Q1 | $498 | Hold |
4
| – | – | ﹤0.01% | 990 |
|
|
2022
Q4 | $1.2K | Hold |
4
| – | – | ﹤0.01% | 875 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 899 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 912 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 948 |
|
|
2021
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 883 |
|
|
2021
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 861 |
|
|
2021
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 871 |
|
|
2021
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 871 |
|
|
2020
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 797 |
|
|
2020
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 827 |
|
|
2020
Q2 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 568 |
|